BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16336434)

  • 1. Atrial and ventricular septal defects can safely be closed by percutaneous intervention.
    Hein R; Büscheck F; Fischer E; Leetz M; Bayard MT; Ostermayer S; Reschke M; Lang K; Römer A; Wilson N; Sievert H
    J Interv Cardiol; 2005 Dec; 18(6):515-22. PubMed ID: 16336434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASD/PFO devices: what is in the pipeline?
    Majunke N; Sievert H
    J Interv Cardiol; 2007 Dec; 20(6):517-23. PubMed ID: 18042057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology Insight: transcatheter closure of ventricular septal defects.
    Moodie DS
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):592-6. PubMed ID: 16258571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
    Szkutnik M; Kusa J; Białkowski J
    Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of congenital muscular ventricular septal defect.
    Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
    J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
    Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial and ventricular shunt closure.
    Majunke N; Sievert H
    J Invasive Cardiol; 2008 Mar; 20(3):E93-6. PubMed ID: 18316844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale and ventricular septal defect closure.
    Wahl A; Meier B
    Heart; 2009 Jan; 95(1):70-82. PubMed ID: 19047442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis and follow-up study on 8 children with combined congenital heart disease treated with simultaneous trans-catheter therapy].
    Cheng SQ; Liu JP; Sun X; Li J; Zhang J; Liu LW; Deng YL; Niu YC
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):599-602. PubMed ID: 18947479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous transcatheter therapy for ventricular septal defect combined with atrial septal defect].
    Li CC; Hu DJ; Pu XQ; Zheng ZF; Chen XB; Zou T; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):446-9. PubMed ID: 16859147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial and ventricular septal defects - epidemiology and spontaneous closure.
    Garne E
    J Matern Fetal Neonatal Med; 2006 May; 19(5):271-6. PubMed ID: 16753766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closure of atrial and ventricular septal defects should be performed by the surgeon.
    Moritz A; Ozaslan F; Dogan S; Abdel-Rahman U; Aybek T; Wimmer-Greinecker G
    J Interv Cardiol; 2005 Dec; 18(6):523-7. PubMed ID: 16336435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of high-risk muscular ventricular septal defects with the CardioSEAL occluder: initial report from the CardioSEAL VSD registry.
    Lim DS; Forbes TJ; Rothman A; Lock JE; Landzberg MJ
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):740-4. PubMed ID: 17621665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter device closure of intracristal ventricular septal defects.
    Gu M; You X; Zhao X; Zheng X; Qin YW
    Am J Cardiol; 2011 Jan; 107(1):110-3. PubMed ID: 21146697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience.
    Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N
    Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.